354 related articles for article (PubMed ID: 28317629)
1. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
Saleem N; Saba R; Maddika S; Weinstein M
Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Disseminated
Kashihara E; Fujita K; Uchida N; Yamamoto Y; Mio T; Koyama H
Am J Trop Med Hyg; 2019 Nov; 101(5):1066-1069. PubMed ID: 31549614
[TBL] [Abstract][Full Text] [Related]
4. Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).
Kuznetcova TI; Sauty A; Herbort CP
Int Ophthalmol; 2012 Oct; 32(5):499-506. PubMed ID: 22661050
[TBL] [Abstract][Full Text] [Related]
5. [A case of pulmonary Mycobacterium kansasii infection with pleural effusion, distinguished from pulmonary tuberculosis].
Kimura Y; Kurosawa T; Hosaka K
Kekkaku; 2014 Sep; 89(9):737-41. PubMed ID: 25730945
[TBL] [Abstract][Full Text] [Related]
6. Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.
Augustynowicz-Kopeć E; Siemion-Szcześniak I; Zabost A; Wyrostkiewicz D; Filipczak D; Oniszh K; Gawryluk D; Radzikowska E; Korzybski D; Szturmowicz M
Pol J Microbiol; 2019; 68(1):15-19. PubMed ID: 31050249
[TBL] [Abstract][Full Text] [Related]
7. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.
Yang C; Luo X; Fan L; Sha W; Xiao H; Cui H
Front Cell Infect Microbiol; 2020; 10():571230. PubMed ID: 33680977
[TBL] [Abstract][Full Text] [Related]
8. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
10. Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.
Hur YG; Crampin AC; Chisambo C; Kanyika J; Houben R; Ndhlovu R; Mzembe T; Lalor MK; Saul J; Branson K; Stanley C; Ngwira B; French N; Ottenhoff TH; Dockrell HM; Gorak-Stolinska P
Clin Vaccine Immunol; 2014 Feb; 21(2):133-42. PubMed ID: 24285818
[TBL] [Abstract][Full Text] [Related]
11. [THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
Mori M; Ageshio F; Kagawa H; Oshitani Y; Fujikawa T; Saito H; Sako H; Yano Y; Kitada S; Maekura R
Kekkaku; 2015 Aug; 90(8):619-23. PubMed ID: 26665518
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.
Shitrit D; Priess R; Peled N; Bishara G; Shlomi D; Kramer MR
Eur J Clin Microbiol Infect Dis; 2007 Oct; 26(10):679-84. PubMed ID: 17629758
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium kansasii pulmonary diseases in Korea.
Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
[TBL] [Abstract][Full Text] [Related]
14. Fatal aortic pseudoaneurysm from disseminated Mycobacterium kansasii infection: case report.
Ehsani L; Reddy SC; Mosunjac M; Kraft CS; Guarner J
Hum Pathol; 2015 Mar; 46(3):467-70. PubMed ID: 25537975
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary
Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease.
Kobashi Y; Mouri K; Miyashita N; Oka M
Jpn J Infect Dis; 2009 May; 62(3):239-41. PubMed ID: 19468192
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
[TBL] [Abstract][Full Text] [Related]
18. Atypical mycobacterial infection in a patient with hairy cell leukemia.
Trizna Z; Tschen J; Natelson EA
Cutis; 2001 Mar; 67(3):241-2. PubMed ID: 11270299
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Hradilek P; Zeman D; Tudik I; Zapletalova O; Ulmann V
Mult Scler; 2014 Apr; 20(5):639-40. PubMed ID: 23959714
[No Abstract] [Full Text] [Related]
20. [Interferon gamma release assay tests and nontuberculous mycobacteria].
Andréjak C; Barras E
Rev Mal Respir; 2018 Oct; 35(8):900-901. PubMed ID: 30220488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
